
Vasave Ulhas Jayant
About Vasave Ulhas Jayant
Data last updated:
Vasave Ulhas Jayant is a Director at Eurasian Cancer Research Council (since 2017), Designated Partner at Occumarine Health Care Llp (since 2019) and Director at Childcan Cancer Foundation (since 2021). The companies operate in Healthcare and Non-Profit Organizations. The 3 current companies with reported revenue have a combined latest revenue of ₹21.3 Lakh; the largest is Eurasian Cancer Research Council at ₹17.2 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Jul 2017 | 2017 | ₹17.2 Lakh (FY 2024) | Active | |
| Designated Partner | 20 Feb 2019 | 2019 | ₹2.3 Lakh (FY 2022) | Active | |
| Director | 16 Mar 2021 | 2021 | ₹1.8 Lakh (FY 2024) | Active |
Board colleagues of Vasave Ulhas Jayant
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dilip Jiva Gavit | 07845592 | Eurasian Cancer Research Council | Director |
| Amol Sadashiv Jadhav | 03509926 | Occumarine Health Care Llp | Designated Partner |
| Namrata Hange Shivajirao | 08368001 | Occumarine Health Care Llp | Designated Partner |
| Niten Kumar Agrawal | 09108275 | Childcan Cancer Foundation | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vasave Ulhas Jayant
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vasave Ulhas Jayant
Vasave Ulhas Jayant currently holds 3 directorships: Eurasian Cancer Research Council (Director, since 21 Jul 2017, revenue ₹17.2 Lakh (FY 2024)); Occumarine Health Care Llp (Designated Partner, since 20 Feb 2019, revenue ₹2.3 Lakh (FY 2022)); Childcan Cancer Foundation (Director, since 16 Mar 2021, revenue ₹1.8 Lakh (FY 2024)).
Vasave Ulhas Jayant was first appointed on 21 Jul 2017 as Director at Eurasian Cancer Research Council. The most recent appointment on record is 16 Mar 2021 at Childcan Cancer Foundation.
The 3 current companies of Vasave Ulhas Jayant that report revenue have a combined latest revenue of ₹21.3 Lakh: Eurasian Cancer Research Council ₹17.2 Lakh (FY 2024); Occumarine Health Care Llp ₹2.3 Lakh (FY 2022); Childcan Cancer Foundation ₹1.8 Lakh (FY 2024).
The current boards of Vasave Ulhas Jayant's companies include Dilip Jiva Gavit (Eurasian Cancer Research Council), Amol Sadashiv Jadhav (Occumarine Health Care Llp), Namrata Hange Shivajirao (Occumarine Health Care Llp), Niten Kumar Agrawal (Childcan Cancer Foundation).